NCT01931644View on ClinicalTrials.gov

At-Home Research Study for Patients With Autoimmune, Inflammatory, Genetic, Hematological, Infectious, Neurological, CNS, Oncological, Respiratory, Metabolic Conditions

CompletedOBSERVATIONAL
Enrollment

17,667

Participants

Timeline

Start Date

July 31, 2013

Primary Completion Date

April 30, 2024

Study Completion Date

April 30, 2024

Conditions
All Diagnosed Health ConditionsADD/ADHDAlopecia AreataAnkylosing SpondylitisAsthmaAtopic Dermatitis EczemaBeta ThalassemiaBipolar DisorderBreast CancerCeliac DiseaseCervical CancerChronic Inflammatory Demyelinating PolyneuropathyChronic Kidney DiseasesChronic Obstructive Pulmonary DiseaseColon CancerColorectal CancerCrohn's DiseaseCystic FibrosisDepressionDiabetes MellitusDuchenne Muscular DystrophyEndometriosisEpilepsyFacioscapulohumeral Muscular DystrophyG6PD DeficiencyGeneral Anxiety DisorderHepatitis BHereditary Hemorrhagic TelangiectasiaHIV/AIDSHuman Papilloma VirusHuntington's DiseaseIdiopathic Thrombocytopenic PurpuraInsomniaKidney CancerLeukemiaLung CancerLupus NephritisLymphomaMelanomaMultiple MyelomaMultiple SclerosisMyositisMyotonic DystrophyOvarian CancerPancreatic CancerParkinson's DiseasePolycystic Kidney DiseasesProstate CancerPsoriasisPsoriatic ArthritisRosaceaSclerodermaSickle Cell AnemiaSickle Cell TraitSjogren's SyndromeSkin CancerSpinal Muscular AtrophySystemic Lupus ErythematosusThrombotic Thrombocytopenic PurpuraTrisomy 21Ulcerative Colitis
Trial Locations (1)

91403

Sanguine Biosciences, Los Angeles

Sponsors
All Listed Sponsors
lead

Sanguine Biosciences

INDUSTRY

NCT01931644 - At-Home Research Study for Patients With Autoimmune, Inflammatory, Genetic, Hematological, Infectious, Neurological, CNS, Oncological, Respiratory, Metabolic Conditions | Biotech Hunter | Biotech Hunter